|
Total properties:
15
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/24/2020
|
Application #:
|
15744636
|
Filing Dt:
|
01/12/2018
|
|
Publication #:
|
|
Pub Dt:
|
02/14/2019
| | | | |
|
Title:
|
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/23/2021
|
Application #:
|
16087604
|
Filing Dt:
|
09/21/2018
|
|
Publication #:
|
|
Pub Dt:
|
08/08/2019
| | | | |
|
Title:
|
COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/22/2019
|
Application #:
|
16363378
|
Filing Dt:
|
03/25/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/18/2019
| | | | |
|
Title:
|
FORMULATIONS OF PIMAVANSERIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/31/2019
|
Application #:
|
16379169
|
Filing Dt:
|
04/09/2019
|
|
Publication #:
|
|
Pub Dt:
|
08/01/2019
| | | | |
|
Title:
|
COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/11/2022
|
Application #:
|
16471543
|
Filing Dt:
|
06/19/2019
|
|
Publication #:
|
|
Pub Dt:
|
07/30/2020
| | | | |
|
Title:
|
PIMAVANSERIN ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF ALZHEIMER?S DISEASE PSYCHOSnt
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/12/2020
|
Application #:
|
16571554
|
Filing Dt:
|
09/16/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/09/2020
| | | | |
|
Title:
|
FORMULATIONS OF PIMAVANSERIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
10/05/2021
|
Application #:
|
16607234
|
Filing Dt:
|
10/22/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/27/2020
| | | | |
|
Title:
|
PIMAVANSERIN FOR TREATING IMPULSE CONTROL DISORDER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/07/2021
|
Application #:
|
16684883
|
Filing Dt:
|
11/15/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/12/2020
| | | | |
|
Title:
|
COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/20/2021
|
Application #:
|
16743607
|
Filing Dt:
|
01/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/28/2020
| | | | |
|
Title:
|
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/20/2021
|
Application #:
|
16786809
|
Filing Dt:
|
02/10/2020
|
|
Publication #:
|
|
Pub Dt:
|
06/11/2020
| | | | |
|
Title:
|
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/01/2020
|
Application #:
|
16836086
|
Filing Dt:
|
03/31/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/16/2020
| | | | |
|
Title:
|
FORMULATIONS OF PIMAVANSERIN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17080731
|
Filing Dt:
|
10/26/2020
|
|
Publication #:
|
|
Pub Dt:
|
09/16/2021
| | | | |
|
Title:
|
FORMULATIONS OF PIMAVANSERIN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17176723
|
Filing Dt:
|
02/16/2021
|
|
Publication #:
|
|
Pub Dt:
|
01/06/2022
| | | | |
|
Title:
|
5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/12/2023
|
Application #:
|
17203266
|
Filing Dt:
|
03/16/2021
|
|
Publication #:
|
|
Pub Dt:
|
01/27/2022
| | | | |
|
Title:
|
METHODS FOR PREPARING N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE AND ITS TARTRATE SALT AND POLYMORPHIC FORM C
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17290479
|
Filing Dt:
|
04/30/2021
|
|
Publication #:
|
|
Pub Dt:
|
01/20/2022
| | | | |
|
Title:
|
METHODS OF TREATING DEPRESSION, ANXIETY AND SEXUAL DYSFUNCTION USING THE COMPOUND PIMAVANSERIN
|
|
